Research Info

Home \Synthesis of ...
Title
Synthesis of novel aryl‑substituted 2‑aminopyridine derivatives by the cascade reaction of 1,1‑enediamines with vinamidinium salts to develop novel anti‑Alzheimer agents
Type Article
Keywords
Aryl vinamidinium salts, Alzheimer, 1,1-Enediamines, Aryl-substituted 2-aminopyridine, Molecular dynamic simulation
Abstract
Alzheimer’s disease (AD), a severe neurodegenerative disorder, imposes socioeconomic burdens and necessitates innovative therapeutic strategies. Current therapeutic interventions are limited and underscore the need for novel inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), enzymes implicated in the pathogenesis of AD. In this study, we report a novel synthetic strategy for the generation of 2-aminopyridine derivatives via a two-component reaction converging aryl vinamidinium salts with 1,1-enediamines (EDAMs) in a dimethyl sulfoxide (DMSO) solvent system, catalyzed by triethylamine ( Et3N). The protocol introduces a rapid, efficient, and scalable synthetic pathway, achieving good to excellent yields while maintaining simplistic workup procedures. Seventeen derivatives were synthesized and subsequently screened for their inhibitory activity against AChE and BChE. The most potent derivative, 3m, exhibited an IC50 value of 34.81 ± 3.71 μM against AChE and 20.66 ± 1.01 μM against BChE compared to positive control donepezil with an IC50 value of 0.079 ± 0.05 μM against AChE and 10.6 ± 2.1 μM against BChE. Also, detailed kinetic studies were undertaken to elucidate their modes of enzymatic inhibition of the most potent compounds against both AChE and BChE. The promising compound was then subjected to molecular docking and dynamics simulations, revealing significant binding affinities and favorable interaction profiles against AChE and BChE. The in silico ADMET assessments further determined the drug-like properties of 3m, suggesting it as a promising candidate for further pre-clinical development.
Researchers ASMA LOORI (First researcher) , hormoz pour taher (Second researcher) , Abdolmohammad Mehranpour (Third researcher) , Alireza Hasaninejad (Fourth researcher) , Mohamadreza Eftekharian (Fifth researcher) , Aida Iraji (Not in first six researchers)